https://farsalinos.github.io/en/tags/pmta/Recent content in PMTA on FarsalinosHugo -- gohugo.ioen© 2026 K. Farsalinos, MD, MPH, PhD | Science & Public HealthSun, 27 Sep 2026 19:20:41 +0300https://farsalinos.github.io/en/news/news_20260927-en/Sat, 26 Sep 2026 00:00:00 +0000https://farsalinos.github.io/en/news/news_20260927-en/<h2 class="relative group">The big picture <div id="the-big-picture" class="anchor"></div> <span class="absolute top-0 w-6 transition-opacity opacity-0 -start-6 not-prose group-hover:opacity-100 select-none"> <a class="text-primary-300 dark:text-neutral-700 !no-underline" href="#the-big-picture" aria-label="Anchor">#</a> </span> </h2> <p>This was a week in which the United States moved further and faster toward a risk-proportionate regulatory posture than at any point so far this year, while India moved sharply in the opposite direction on nicotine pouches. Reporting emerged that the FDA is preparing to revisit the core 2021 rule governing premarket tobacco applications, CTP Director Bret Koplow&rsquo;s harm-reduction framing continued to shape coverage of the agency, and a Senate confirmation hearing put flavored-vape policy back in the spotlight. Meanwhile, India ordered a nationwide crackdown on nicotine pouches, Canada&rsquo;s health minister rebuffed industry calls to loosen pouch rules, and Philip Morris International expanded heated-tobacco access in the Gulf. A new Scotland-based study added fresh data on the comparative effectiveness of quitting aids.</p>